2nd Quarter - Report

BOCKORNY GROUP, INC. for CVS HEALTH INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to drug pricing Issues related to health reform proposals Issues related to representation in COVID-19-related packages

LobbyistCovered position, as disclosed
JEFFREY MAXWELL BECKER New Coalition Coordinator - House Republican Conference Staff Assistant - Rep. Liz Cheney
DAVID BOCKORNY —
MARTIN DEPOY New —

Contacted: White House Office; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Executive Office of the President (EOP)

Budget/Appropriations BUD

Issues related to hospital payments Issues related to hospital inclusion and representation in COVID-19 packages Public Law Number 116-136 CARES Act H.R. 133 Consolidated Appropriations Act, 2021 H.R. 1868 An Act to prevent across-the-board direct spending cuts, and for other purposes HR 5376 Build Back Better Act Budget Reconciliation Legislative Recommendations Relating to Medicaid; Budget Reconciliation Legislative Recommendations Relating to CHIP; Budget Reconciliation Legislative Recommendations Relating to Medicare (Sec. 30801, 30803, 30804, 30805)

LobbyistCovered position, as disclosed
JEFFREY MAXWELL BECKER New —
DAVID BOCKORNY —
MARTIN DEPOY New —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 133 (117th), H.R. 1868 (117th), H.R. 5376 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.